Cure One, Cure Many Award in Neuroinflammation
There are over 600 known brain diseases, and neuroinflammation plays a role in nearly all of them. Almost every major pediatric, adult, and geriatric neurological and neuropsychiatric disorder involves complex changes in the brain’s inflammatory response.
Insights into neuroinflammation’s role in brain health will allow us to more precisely target conditions as different as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, ALS, stroke, brain tumor, epilepsy, migraine, chronic pain, myopathy and neuropathy, traumatic brain injury, schizophrenia, encephalitis, and COVID-19-associated brain disease. Together, these diseases and disorders affect 60% of the U.S. population and over 3 billion people worldwide. They attack the essence of what makes us human: thought, speech, emotion, and movement.
Exploring the Role of Neuroinflammation in Brain Disease
The Cure One, Cure Many Award in Neuroinflammation is a groundbreaking, multimillion-dollar research initiative focused on better understanding neuroinflammation’s role in brain disease, and promises to transform the future of brain health. This unprecedented, cross-industry collaboration between scientists, disease-specific organizations like the National MS Society, industry leaders like Genentech, and patient advocacy groups, will unlock possibilities for early detection and innovative new therapies.
This collaboration between organizations directly supports our philosophy of “Cure One, Cure Many“, a commitment to investing in research across the full spectrum of brain diseases and disorders.
By investing in research across a range of diseases and disorders, we improve our chances of identifying these connections. When we find the cure for one brain disease, we will find cures to many others.
